Cargando…

Host histone acetylation unlocks HDAC inhibitor potential

Detalles Bibliográficos
Autores principales:	Terranova-Barberio, Manuela, Thomas, Scott, Munster, Pamela N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739717/ https://www.ncbi.nlm.nih.gov/pubmed/29290932 http://dx.doi.org/10.18632/oncotarget.22422

Ejemplares similares

HDAC inhibition potentiates immunotherapy in triple negative breast cancer
por: Terranova-Barberio, Manuela, et al.
Publicado: (2017)

Protein Acetylation and the Physiological Role of HDACs
por: Matthias, Patrick, et al.
Publicado: (2011)

An ELISA method to assess HDAC inhibitor-induced alterations to P. falciparum histone lysine acetylation
por: Hesping, Eva, et al.
Publicado: (2020)

Hepcidin is regulated by promoter-associated histone acetylation and HDAC3
por: Pasricha, Sant-Rayn, et al.
Publicado: (2017)

Effect of the HDAC Inhibitor on Histone Acetylation and Methyltransferases in A2780 Ovarian Cancer Cells
por: Natarajan, Umamaheswari, et al.
Publicado: (2021)

The potential for histone deacetylase (HDAC) inhibitors as cestocidal drugs
por: Vaca, Hugo Rolando, et al.
Publicado: (2021)

Unlocking the Potential of Biomarkers for Immune Checkpoint Inhibitors in Cancer Therapy
por: Dal Collo, Giada, et al.
Publicado: (2023)

Alkylating agents induce histone H3K18 hyperacetylation and potentiate HDAC inhibitor-mediated global histone acetylation and cytotoxicity in mantle cell lymphoma
por: Hiraoka, N, et al.
Publicado: (2013)

Histone deacetylase (HDAC) 1 and 2 complexes regulate both histone acetylation and crotonylation in vivo
por: Kelly, R. D. W., et al.
Publicado: (2018)

Expression of acetylated histones H3 and H4 and histone deacetylase enzymes HDAC1, HDAC2 and HDAC6 in simple mammary carcinomas of female dogs
por: Senhorello, Igor Luiz Salardani, et al.
Publicado: (2023)

Induction of histone deacetylases (HDACs) in human abdominal aortic aneurysm: therapeutic potential of HDAC inhibitors
por: Galán, María, et al.
Publicado: (2016)

Genomic targets, and histone acetylation and gene expression profiling of neural HDAC inhibition
por: Lopez-Atalaya, Jose P., et al.
Publicado: (2013)

Histone Deacetylase (HDAC) Inhibitors for the Treatment of Schistosomiasis
por: Ghazy, Ehab, et al.
Publicado: (2022)

Microbiome-host-immune crosstalk: mining the microbiome: a treasure trove waiting to be unlocked
por: Noti, Mario, et al.
Publicado: (2021)

Acetylation and Histone Deacetylase Inhibitors in Cancer
por: Kortenhorst, Madeleine S. Q., et al.
Publicado: (2006)

Unlocking the Secret to Higher Crop Yield: The Potential for Histone Modifications
por: Fang, Weiwei, et al.
Publicado: (2023)

Unlocking the full potential of probiotics: refocusing on microbial demands
por: Joossens, Marie
Publicado: (2020)

Acetylation: a new key to unlock tau’s role in neurodegeneration
por: Cook, Casey, et al.
Publicado: (2014)

Myelodysplastic Syndrome and Histone Deacetylase Inhibitors: “To Be or Not to Be Acetylated”?
por: Stintzing, Sebastian, et al.
Publicado: (2011)

Unlocking the potential of targeting histone-modifying enzymes for treating IBD and CRC
por: Liang, Bing, et al.
Publicado: (2023)

Unlocking the potential of molecular-driven stratification for osteosarcoma treatment and prognosis
por: Moquin-Beaudry, Gaël, et al.
Publicado: (2023)

The Role of Dietary Histone Deacetylases (HDACs) Inhibitors in Health and Disease
por: Bassett, Shalome A., et al.
Publicado: (2014)

In silico modification of suberoylanilide hydroxamic acid (SAHA) as potential inhibitor for class II histone deacetylase (HDAC)
por: Tambunan, Usman SF, et al.
Publicado: (2011)

Optimization of Resveratrol Used as a Scaffold to Design Histone Deacetylase (HDAC-1 and HDAC-2) Inhibitors
por: Urias, Beatriz Silva, et al.
Publicado: (2022)

Design and in silico screening of aryl allyl mercaptan analogs as potential histone deacetylases (HDAC) inhibitors
por: Singhal, Sugandha, et al.
Publicado: (2020)

The Crosstalk between Acetylation and Phosphorylation: Emerging New Roles for HDAC Inhibitors in the Heart
por: Habibian, Justine, et al.
Publicado: (2018)

Pan-HDAC Inhibitors Promote Tau Aggregation by Increasing the Level of Acetylated Tau
por: Jeong, Hyeanjeong, et al.
Publicado: (2019)

Kinetically selective inhibitors of histone deacetylase 2 (HDAC2) as cognition enhancers
por: Wagner, F. F., et al.
Publicado: (2015)

Unlocking the Potential of Dental-Derived Mesenchymal Stem Cells in Regenerative Medicine
por: Tatullo, Marco, et al.
Publicado: (2023)

HDAC11 inhibition disrupts porcine oocyte meiosis via regulating α-tubulin acetylation and histone modifications
por: Huang, Rong, et al.
Publicado: (2021)

Balancing Histone Deacetylase (HDAC) Inhibition and Drug‐likeness: Biological and Physicochemical Evaluation of Class I Selective HDAC Inhibitors
por: Schäker‐Hübner, Linda, et al.
Publicado: (2022)

Developing selective histone deacetylases (HDACs) inhibitors through ebselen and analogs
por: Wang, Yuren, et al.
Publicado: (2017)

Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy
por: Wagner, Julia M., et al.
Publicado: (2010)

Structure-Based Inhibitor Discovery of Class I Histone Deacetylases (HDACs)
por: Luo, Yuxiang, et al.
Publicado: (2020)

Activation of p21 by HDAC Inhibitors Requires Acetylation of H2A.Z
por: Bellucci, Luca, et al.
Publicado: (2013)

N(ɛ)-acetyl lysine derivatives with zinc binding groups as novel HDAC inhibitors
por: Wang, Fang, et al.
Publicado: (2019)

Elevated HDAC activity and altered histone phospho-acetylation confer acquired radio-resistant phenotype to breast cancer cells
por: Sharda, Asmita, et al.
Publicado: (2020)

Expression of non-secreted IL-4 is associated with HDAC inhibitor-induced cell death, histone acetylation and c-Jun regulation in human gamma/delta T-cells
por: Bhat, Jaydeep, et al.
Publicado: (2016)

Getting a GRP on histone deacetylase inhibitor selectivity
por: Ding, Husheng, et al.
Publicado: (2017)

Hydroxyl Ketone-Based Histone Deacetylase Inhibitors To Gain Insight into Class I HDAC Selectivity versus That of HDAC6
por: Traoré, Mohamed D. M., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vq5tqar6bh952g5e0am0f7m3go